At this point, 96.7% (554) were discharged and the remaining 19/573 (3.3%) were followed up for reasons including raised PSA (prostate specific antigen), lower urinary tract symptoms, and urolithiasis. The gene discussed is KLK3; the disease is urolithiasis.